GUT LINK: A Study of a Care Pathway Across Primary and GI Specialty Care

Last updated: February 14, 2024
Sponsor: Michael Stewart
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lactose Intolerance

Gastrointestinal Diseases And Disorders

Colic

Treatment

GUT LINK SmartPath

Clinical Study ID

NCT05725954
50762
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

It can be challenging for Primary Healthcare Providers (PHCPs) to differentiate between IBS and more serious illnesses involving the GI tract, such as Crohn's disease, ulcerative colitis, or cancer. To help with diagnosis and treatment of IBS, evidence-based guidelines have been developed. However, they are not commonly used in primary care practice and PHCPs and patients often feel that GI specialist evaluation and endoscopy is required. The development of care pathways and clinical practice guidelines is essential to support the investigation and management of digestive diseases, such as IBS.

The current pilot study is designed to assess the implementation and early comparative effectiveness of a Clinical Care Pathway for lower GI tract symptoms.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Must be a general practitioner
  • Have a family practice in Nova Scotia, Canada
  • Utilize the platform 'virtual hallway' as part of current referral practices
  • Deliver care to patients with lower GI complaints

Exclusion

Exclusion Criteria:

  • None

Study Design

Total Participants: 120
Treatment Group(s): 1
Primary Treatment: GUT LINK SmartPath
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
December 31, 2026

Connect with a study center

  • QEII Health Sciences Centre

    Halifax, Nova Scotia B3N 2Z6
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.